{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T10:29:03Z","timestamp":1786616943630,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014426","name":"American Board of Psychiatry and Neurology Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011500","name":"Abigail Wexner Research Institute at Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008747","name":"The Ohio State University Center for Clinical and Translational Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ymthe.2024.03.034","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:03:48Z","timestamp":1711544628000},"page":"1701-1720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9108-1840","authenticated-orcid":false,"given":"Jessica A.","family":"Herstine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Kai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiy","family":"Chornyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara J.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"Sunshine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenia","family":"Nokhrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Rediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Holaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nettie K.","family":"Pyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bratasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Flanigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Bonkowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-3743","authenticated-orcid":false,"given":"Allison M.","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.03.034_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.25287","article-title":"Natural History of Vanishing White Matter","volume":"84","author":"Hamilton","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/WNL.48.4.845","article-title":"A new leukoencephalopathy with vanishing white matter","volume":"48","author":"van der Knaap","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2024.03.034_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(06)70440-9","article-title":"Vanishing white matter disease","volume":"5","author":"van der Knaap","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib4","first-page":"837","article-title":"[Clinical features of 54 cases of leukoencephalopathy with vanishing white matter disease in children]","volume":"57","author":"Zhou","year":"2019","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.ymthe.2024.03.034_bib5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1212\/01.WNL.0000123259.67815.DB","article-title":"The effect of genotype on the natural history of eIF2B-related leukodystrophies","volume":"62","author":"Fogli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2024.03.034_bib6","first-page":"345","article-title":"13 eIF2\u03b1 Phosphorylation in Cellular Stress Responses and Disease","volume":"48","author":"Ron","year":"2007","journal-title":"Cold Spring Harb. Monogr. Arch."},{"key":"10.1016\/j.ymthe.2024.03.034_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/acs.biochem.0c00132","article-title":"eIF2B and the Integrated Stress Response: A Structural and Mechanistic View","volume":"59","author":"Marintchev","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2024.03.034_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65703","article-title":"eIF2B conformation and assembly state regulate the integrated stress response","volume":"10","author":"Schoof","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2024.03.034_bib9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2024.03.034_bib10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/acn3.50826","article-title":"Vanishing white matter: deregulated integrated stress response as therapy target","volume":"6","author":"Abbink","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1261\/rna.066563.118","article-title":"EIF2B2 mutations in vanishing white matter disease hypersuppress translation and delay recovery during the integrated stress response","volume":"24","author":"Moon","year":"2018","journal-title":"Rna"},{"key":"10.1016\/j.ymthe.2024.03.034_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.jnen.0000228201.27539.50","article-title":"Glia-Specific Activation of All Pathways of the Unfolded Protein Response in Vanishing White Matter Disease","volume":"65","author":"van Kollenburg","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42940","article-title":"eIF2B activator prevents neurological defects caused by a chronic integrated stress response","volume":"8","author":"Wong","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2024.03.034_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jnc.14887","article-title":"Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model","volume":"154","author":"Terumitsu-Tsujita","year":"2020","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2024.03.034_bib15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00498","article-title":"Pharmacological brake-release of mRNA translation enhances cognitive memory","volume":"2","author":"Sidrauski","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2024.03.034_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.07314","article-title":"Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response","volume":"4","author":"Sidrauski","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2024.03.034_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32733","article-title":"The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes","volume":"7","author":"Wong","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2024.03.034_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05033","article-title":"The small molecule ISRIB reverses the effects of eIF2alpha phosphorylation on translation and stress granule assembly","volume":"4","author":"Sidrauski","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2024.03.034_bib19","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1172\/JCI83908","article-title":"Astrocytes are central in the pathomechanisms of vanishing white matter","volume":"126","author":"Dooves","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.03.034_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nm1195","article-title":"EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy","volume":"11","author":"Dietrich","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.03.034_bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/bpa.12606","article-title":"Vanishing white matter: a leukodystrophy due to astrocytic dysfunction","volume":"28","author":"Bugiani","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56319","article-title":"Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response","volume":"9","author":"Keefe","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2024.03.034_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/brain\/aws320","article-title":"Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease","volume":"136","author":"Bugiani","year":"2013","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2024.03.034_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2021.100876","article-title":"Recent Advancements in the Diagnosis and Treatment of Leukodystrophies","volume":"37","author":"Bradbury","year":"2021","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","article-title":"AAV-based in\u00a0vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2024.03.034_bib26","series-title":"FDA Approves Innovative Gene Therapy to Treat Pediatric Patients with Spinal Muscular Atrophy, a Rare Disease and Leading Genetic Cause of Infant Mortality","year":"2019"},{"key":"10.1016\/j.ymthe.2024.03.034_bib27","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1172\/JCI133953","article-title":"Krabbe disease successfully treated via monotherapy of intrathecal gene therapy","volume":"130","author":"Bradbury","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.03.034_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11689-018-9234-0","article-title":"Recent progress and considerations for AAV gene therapies targeting the central nervous system","volume":"10","author":"Lykken","year":"2018","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.ymthe.2024.03.034_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065646","article-title":"Glial promoter selectivity following AAV-delivery to the immature brain","volume":"8","author":"von Jonquieres","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.03.034_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/glia.20622","article-title":"GFAP promoter elements required for region-specific and astrocyte-specific expression","volume":"56","author":"Lee","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2024.03.034_bib31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0168-8278(96)80269-8","article-title":"Glial fibrillary acidic protein--a cell type specific marker for Ito cells in\u00a0vivo and in\u00a0vitro","volume":"24","author":"Neubauer","year":"1996","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib32","first-page":"1069","article-title":"The hepatic perisinusoidal stellate cell","volume":"12","author":"Kawada","year":"1997","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0165-5728(85)80073-4","article-title":"Extra-neural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver","volume":"8","author":"Gard","year":"1985","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/acn3.207","article-title":"Aggregation of MBP in chronic demyelination","volume":"2","author":"Frid","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.omtm.2022.02.006","article-title":"In\u00a0vivo targeting of a variant causing vanishing white matter using CRISPR\/Cas9","volume":"25","author":"Hillen","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.03.034_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008318","article-title":"Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders","volume":"4","author":"Horzinski","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.03.034_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.ejhg.5201189","article-title":"Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients","volume":"12","author":"Fogli","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2024.03.034_bib38","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/humu.21535","article-title":"Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes","volume":"32","author":"Liu","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2024.03.034_bib39","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/MCB.24.8.3295-3306.2004","article-title":"Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways","volume":"24","author":"Li","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib40","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.jnen.0000178446.41595.3a","article-title":"The unfolded protein response in vanishing white matter disease","volume":"64","author":"van der Voorn","year":"2005","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2024.03.034_bib41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/bioinformatics\/btt764","article-title":"CasOT: a genome-wide Cas9\/gRNA off-target searching tool","volume":"30","author":"Xiao","year":"2014","journal-title":"Bioinformatics"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624002120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624002120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:24:22Z","timestamp":1776803062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624002120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1525001624002120"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.034","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}